🟢 Krystal Biotech is trading 4.4% up today as it rebounds from a recent pullback

Krystal Biotech is trading at $379.41 (4.4% up) in after-hours trading, rebounding from a modest recent pullback.

• The advance appears to be a continuation of the broader bullish trend fueled by strong Vyjuvek-driven fundamentals rather than a new discrete catalyst.
• There are no fresh company-specific headlines, earnings releases, or major analyst calls dated July 13–14, 2026, that directly explain the price move.
• The stock is showing resilience as it recovers ground following a period of consolidation.